Clin Res Cardiol (2021)
DOI DOI https://doi.org/10.1007/s00392-021-01843-w

The endothelial lncRNA NTRAS safeguards vascular integrity through regulating TJP1 isoform expression
Y. Fouani1, L. Kirchhof1, L. Stanicek1, A. Heumuller1, G. Luxán1, A. Knau1, A. Fischer1, D. John1, P. Neumann1, K. Devraj2, R. Boon1, S. Liebner2, A. Bindereif3, I. Wittig4, C. Mogler5, M. Karimova6, S. Dimmeler1, N. Jaé1
1Zentrum für Molekulare Medizin, Institut für Kardiovaskuläre Regeneration, Goethe Universität Frankfurt am Main, Frankfurt am Main; 2Institute of Neurology (Edinger-Institute), Goethe Universität, Frankfurt; 3Institute of Biochemistry, Justus-Liebig-Universität Giessen, Gießen; 4Functional Proteomics, Goethe Universität, Frankfurt am Main; 5Institute of Pathology, Technische Universität München (TUM), Munich; 6Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Goethe Universität Frankfurt am Main, Frankfurt am Main;

The semi-selective barrier provided by the endothelium ensures vascular integrity and tissue homeostasis. Under physiological conditions, interendothelial junction-complexes, including adherence and tight junctions, orchestrate vascular permeability in tissue-specific manner. In contrast, disintegration of these complexes is a hallmark of several detrimental pathologies including inflammation, oedema, and tissue ischemia. A huge endeavour has been made to understand the molecular mechanisms and pathways controlling endothelial barrier function; however, little is still known regarding the role of long non-coding RNAs in this context.

Here we report on the endothelial-enriched lncRNA NTRAS as a gatekeeper of endothelial barrier function. In vivo, pharmacological Ntras silencing suffices to induce vascular leakage, demonstrated by increased extravasation of FTSC-dextran (123 ± 10%) and TMR-dextran (172 ± 27%) in murine heart tissue. Strikingly, Ntras-deficient mice showed a significantly reduced survival (-25% during 10 days follow up; p=0.01). Besides, ~60% of Ntras-silenced mice exhibited a broad range of cardiac pathologies, ranging from mild inflammation to severe defects such as myocarditis and scar formation (p<0.05). Mechanistically, we demonstrate NTRAS to interact with hnRNPL to fine-tune alternative splicing of tight junction protein 1 (TJP1) pre-mRNA, eventually regulating endothelial permeability. Specifically, by sequestration of the splicing regulator hnRNPL, NTRAS promotes the expression of the so-called TJP1a+ isoform which we found to contribute to endothelial resistance. In contrast, NTRAS silencing and targeted splicing modulation increase TJP1a- expression, and thereby impaired barrier function. Deleting a bona fide motif within Ntras, serving as a binding site for hnRNPL, impaired cardiac vascular integrity and manifested as induced tracer penetration (FTSC-dextran 147 ± 15%; TMR-dextran 163 ± 21%; p<0.05). At the same time, these mice showed induced cardiac inflammation characterized by an increased CD45+ cells infiltration (299 ± 34%; p<0.001) into heart tissue.

Collectively, we unveil NTRAS as a constituent of a splicing-regulatory network detrimental in sustaining vascular integrity through preserving the equilibrium between TJP1α+ and α- isoforms. These results further expand our knowledge regarding the physiological roles of lncRNAs in vascular biology, especially in the context of regulating barrier function.


https://dgk.org/kongress_programme/jt2021/aP1582.html